DSGN Design Therapeutics RESULTS: Q2, Q2 operating expenses $22.177M, Q2 Net Income $-20.165M vs. EST $-21.3M, Q2 Operating Income $-22.177M
DSGN Design Therapeutics RESULTS: Q2, Q2 operating expenses $22.177M, Q2 Net Income $-20.165M vs. EST $-21.3M, Q2 Operating Income $-22.177M, Q2 basic EPS $-0.32
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.